Published in Law and Health Weekly, April 22nd, 2006
The study, prepared by Avalere Health, was released by the California HealthCare Foundation and will be presented to the California State Assembly.
Using its proprietary DataFrame tool, Avalere Health analyzed CMS' publicly available data from October 2005 to assess if drug coverage for California's dual-eligible beneficiaries is better or worse after the transition to Part D drug plans. Their evaluation of the 10 prescription drug plans...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.